[1]
Le Bars PL, Katz MM, Berman N, Itil TM, Freedman AM, Schatzberg AF. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group. JAMA. 1997 Oct 22-29:278(16):1327-32
[PubMed PMID: 9343463]
Level 1 (high-level) evidence
[2]
Herrschaft H, Nacu A, Likhachev S, Sholomov I, Hoerr R, Schlaefke S. Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg. Journal of psychiatric research. 2012 Jun:46(6):716-23. doi: 10.1016/j.jpsychires.2012.03.003. Epub 2012 Mar 27
[PubMed PMID: 22459264]
Level 1 (high-level) evidence
[3]
Schneider LS, DeKosky ST, Farlow MR, Tariot PN, Hoerr R, Kieser M. A randomized, double-blind, placebo-controlled trial of two doses of Ginkgo biloba extract in dementia of the Alzheimer's type. Current Alzheimer research. 2005 Dec:2(5):541-51
[PubMed PMID: 16375657]
Level 1 (high-level) evidence
[4]
Birks J, Grimley Evans J. Ginkgo biloba for cognitive impairment and dementia. The Cochrane database of systematic reviews. 2009 Jan 21:(1):CD003120. doi: 10.1002/14651858.CD003120.pub3. Epub 2009 Jan 21
[PubMed PMID: 19160216]
Level 1 (high-level) evidence
[5]
Butler M, Nelson VA, Davila H, Ratner E, Fink HA, Hemmy LS, McCarten JR, Barclay TR, Brasure M, Kane RL. Over-the-Counter Supplement Interventions to Prevent Cognitive Decline, Mild Cognitive Impairment, and Clinical Alzheimer-Type Dementia: A Systematic Review. Annals of internal medicine. 2018 Jan 2:168(1):52-62. doi: 10.7326/M17-1530. Epub 2017 Dec 19
[PubMed PMID: 29255909]
Level 1 (high-level) evidence
[6]
Tan MS, Yu JT, Tan CC, Wang HF, Meng XF, Wang C, Jiang T, Zhu XC, Tan L. Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis. Journal of Alzheimer's disease : JAD. 2015:43(2):589-603. doi: 10.3233/JAD-140837. Epub
[PubMed PMID: 25114079]
Level 1 (high-level) evidence
[7]
Yuan Q, Wang CW, Shi J, Lin ZX. Effects of Ginkgo biloba on dementia: An overview of systematic reviews. Journal of ethnopharmacology. 2017 Jan 4:195():1-9. doi: 10.1016/j.jep.2016.12.005. Epub 2016 Dec 7
[PubMed PMID: 27940086]
Level 3 (low-level) evidence
[8]
DeKosky ST, Williamson JD, Fitzpatrick AL, Kronmal RA, Ives DG, Saxton JA, Lopez OL, Burke G, Carlson MC, Fried LP, Kuller LH, Robbins JA, Tracy RP, Woolard NF, Dunn L, Snitz BE, Nahin RL, Furberg CD, Ginkgo Evaluation of Memory (GEM) Study Investigators. Ginkgo biloba for prevention of dementia: a randomized controlled trial. JAMA. 2008 Nov 19:300(19):2253-62. doi: 10.1001/jama.2008.683. Epub
[PubMed PMID: 19017911]
Level 1 (high-level) evidence
[9]
Vellas B, Coley N, Ousset PJ, Berrut G, Dartigues JF, Dubois B, Grandjean H, Pasquier F, Piette F, Robert P, Touchon J, Garnier P, Mathiex-Fortunet H, Andrieu S, GuidAge Study Group. Long-term use of standardised Ginkgo biloba extract for the prevention of Alzheimer's disease (GuidAge): a randomised placebo-controlled trial. The Lancet. Neurology. 2012 Oct:11(10):851-9. doi: 10.1016/S1474-4422(12)70206-5. Epub 2012 Sep 6
[PubMed PMID: 22959217]
Level 1 (high-level) evidence
[10]
Charemboon T, Jaisin K. Ginkgo biloba for prevention of dementia: a systematic review and meta-analysis. Journal of the Medical Association of Thailand = Chotmaihet thangphaet. 2015 May:98(5):508-13
[PubMed PMID: 26058281]
Level 1 (high-level) evidence
[11]
Laws KR, Sweetnam H, Kondel TK. Is Ginkgo biloba a cognitive enhancer in healthy individuals? A meta-analysis. Human psychopharmacology. 2012 Nov:27(6):527-33. doi: 10.1002/hup.2259. Epub 2012 Sep 24
[PubMed PMID: 23001963]
Level 1 (high-level) evidence
[12]
Zeng X, Liu M, Yang Y, Li Y, Asplund K. Ginkgo biloba for acute ischaemic stroke. The Cochrane database of systematic reviews. 2005 Oct 19:2005(4):CD003691
[PubMed PMID: 16235335]
Level 1 (high-level) evidence
[13]
Li S, Zhang X, Fang Q, Zhou J, Zhang M, Wang H, Chen Y, Xu B, Wu Y, Qian L, Xu Y. Ginkgo biloba extract improved cognitive and neurological functions of acute ischaemic stroke: a randomised controlled trial. Stroke and vascular neurology. 2017 Dec:2(4):189-197. doi: 10.1136/svn-2017-000104. Epub 2017 Dec 18
[PubMed PMID: 29507779]
Level 2 (mid-level) evidence
[14]
Wu YZ, Li SQ, Zu XG, Du J, Wang FF. Ginkgo biloba extract improves coronary artery circulation in patients with coronary artery disease: contribution of plasma nitric oxide and endothelin-1. Phytotherapy research : PTR. 2008 Jun:22(6):734-9. doi: 10.1002/ptr.2335. Epub
[PubMed PMID: 18446847]
[15]
Kuller LH, Ives DG, Fitzpatrick AL, Carlson MC, Mercado C, Lopez OL, Burke GL, Furberg CD, DeKosky ST, Ginkgo Evaluation of Memory Study Investigators. Does Ginkgo biloba reduce the risk of cardiovascular events? Circulation. Cardiovascular quality and outcomes. 2010 Jan:3(1):41-7. doi: 10.1161/CIRCOUTCOMES.109.871640. Epub 2009 Nov 24
[PubMed PMID: 20123670]
Level 2 (mid-level) evidence
[16]
Nicolaï SP, Kruidenier LM, Bendermacher BL, Prins MH, Stokmans RA, Broos PP, Teijink JA. Ginkgo biloba for intermittent claudication. The Cochrane database of systematic reviews. 2013 Jun 6:2013(6):CD006888. doi: 10.1002/14651858.CD006888.pub3. Epub 2013 Jun 6
[PubMed PMID: 23744597]
Level 1 (high-level) evidence
[17]
Brinkley TE, Lovato JF, Arnold AM, Furberg CD, Kuller LH, Burke GL, Nahin RL, Lopez OL, Yasar S, Williamson JD, Ginkgo Evaluation of Memory (GEM) Study Investigators. Effect of Ginkgo biloba on blood pressure and incidence of hypertension in elderly men and women. American journal of hypertension. 2010 May:23(5):528-33. doi: 10.1038/ajh.2010.14. Epub 2010 Feb 18
[PubMed PMID: 20168306]
[18]
Momtazi-Borojeni AA, Katsiki N, Pirro M, Banach M, Rasadi KA, Sahebkar A. Dietary natural products as emerging lipoprotein(a)-lowering agents. Journal of cellular physiology. 2019 Aug:234(8):12581-12594. doi: 10.1002/jcp.28134. Epub 2019 Jan 13
[PubMed PMID: 30637725]
[19]
Aziz TA, Hussain SA, Mahwi TO, Ahmed ZA, Rahman HS, Rasedee A. The efficacy and safety of Ginkgo biloba extract as an adjuvant in type 2 diabetes mellitus patients ineffectively managed with metformin: a double-blind, randomized, placebo-controlled trial. Drug design, development and therapy. 2018:12():735-742. doi: 10.2147/DDDT.S157113. Epub 2018 Apr 5
[PubMed PMID: 29670330]
Level 1 (high-level) evidence
[20]
Dai CX, Hu CC, Shang YS, Xie J. Role of Ginkgo biloba extract as an adjunctive treatment of elderly patients with depression and on the expression of serum S100B. Medicine. 2018 Sep:97(39):e12421. doi: 10.1097/MD.0000000000012421. Epub
[PubMed PMID: 30278520]
[21]
Zhang WF, Tan YL, Zhang XY, Chan RC, Wu HR, Zhou DF. Extract of Ginkgo biloba treatment for tardive dyskinesia in schizophrenia: a randomized, double-blind, placebo-controlled trial. The Journal of clinical psychiatry. 2011 May:72(5):615-21. doi: 10.4088/JCP.09m05125yel. Epub 2010 Sep 21
[PubMed PMID: 20868638]
Level 1 (high-level) evidence
[22]
Savaskan E, Mueller H, Hoerr R, von Gunten A, Gauthier S. Treatment effects of Ginkgo biloba extract EGb 761® on the spectrum of behavioral and psychological symptoms of dementia: meta-analysis of randomized controlled trials. International psychogeriatrics. 2018 Mar:30(3):285-293. doi: 10.1017/S1041610217001892. Epub 2017 Sep 21
[PubMed PMID: 28931444]
Level 1 (high-level) evidence
[23]
Wheatley D. Triple-blind, placebo-controlled trial of Ginkgo biloba in sexual dysfunction due to antidepressant drugs. Human psychopharmacology. 2004 Dec:19(8):545-8
[PubMed PMID: 15378664]
[24]
Ito TY, Polan ML, Whipple B, Trant AS. The enhancement of female sexual function with ArginMax, a nutritional supplement, among women differing in menopausal status. Journal of sex & marital therapy. 2006 Oct-Dec:32(5):369-78
[PubMed PMID: 16959660]
[25]
Haguenauer JP, Cantenot F, Koskas H, Pierart H. [Treatment of equilibrium disorders with Ginkgo biloba extract. A multicenter double-blind drug vs. placebo study]. Presse medicale (Paris, France : 1983). 1986 Sep 25:15(31):1569-72
[PubMed PMID: 2947102]
Level 1 (high-level) evidence
[26]
Sokolova L, Hoerr R, Mishchenko T. Treatment of Vertigo: A Randomized, Double-Blind Trial Comparing Efficacy and Safety of Ginkgo biloba Extract EGb 761 and Betahistine. International journal of otolaryngology. 2014:2014():682439. doi: 10.1155/2014/682439. Epub 2014 Jun 25
[PubMed PMID: 25057270]
Level 1 (high-level) evidence
[27]
Hilton MP, Zimmermann EF, Hunt WT. Ginkgo biloba for tinnitus. The Cochrane database of systematic reviews. 2013 Mar 28:(3):CD003852. doi: 10.1002/14651858.CD003852.pub3. Epub 2013 Mar 28
[PubMed PMID: 23543524]
Level 1 (high-level) evidence
[28]
Kramer F, Ortigoza Á. Ginkgo biloba for the treatment of tinnitus. Medwave. 2018 Oct 17:18(6):e7295. doi: 10.5867/medwave.2018.06.7294. Epub 2018 Oct 17
[PubMed PMID: 30339143]
[29]
Parsad D, Pandhi R, Juneja A. Effectiveness of oral Ginkgo biloba in treating limited, slowly spreading vitiligo. Clinical and experimental dermatology. 2003 May:28(3):285-7
[PubMed PMID: 12780716]
[30]
Evans JR. Ginkgo biloba extract for age-related macular degeneration. The Cochrane database of systematic reviews. 2000:(2):CD001775
[PubMed PMID: 10796819]
Level 1 (high-level) evidence
[31]
Loskutova E, O'Brien C, Loskutov I, Loughman J. Nutritional supplementation in the treatment of glaucoma: A systematic review. Survey of ophthalmology. 2019 Mar-Apr:64(2):195-216. doi: 10.1016/j.survophthal.2018.09.005. Epub 2018 Oct 6
[PubMed PMID: 30296451]
Level 3 (low-level) evidence
[32]
Gertsch JH, Basnyat B, Johnson EW, Onopa J, Holck PS. Randomised, double blind, placebo controlled comparison of ginkgo biloba and acetazolamide for prevention of acute mountain sickness among Himalayan trekkers: the prevention of high altitude illness trial (PHAIT). BMJ (Clinical research ed.). 2004 Apr 3:328(7443):797
[PubMed PMID: 15070635]
Level 1 (high-level) evidence
[33]
Sridharan K, Sivaramakrishnan G. Pharmacological interventions for preventing acute mountain sickness: a network meta-analysis and trial sequential analysis of randomized clinical trials. Annals of medicine. 2018 Mar:50(2):147-155. doi: 10.1080/07853890.2017.1407034. Epub 2017 Nov 23
[PubMed PMID: 29166795]
Level 1 (high-level) evidence
[35]
Marcilhac A, Dakine N, Bourhim N, Guillaume V, Grino M, Drieu K, Oliver C. Effect of chronic administration of Ginkgo biloba extract or Ginkgolide on the hypothalamic-pituitary-adrenal axis in the rat. Life sciences. 1998:62(25):2329-40
[PubMed PMID: 9651122]
[36]
White HL, Scates PW, Cooper BR. Extracts of Ginkgo biloba leaves inhibit monoamine oxidase. Life sciences. 1996:58(16):1315-21
[PubMed PMID: 8614288]
[37]
Rojas P, Rojas C, Ebadi M, Montes S, Monroy-Noyola A, Serrano-García N. EGb761 pretreatment reduces monoamine oxidase activity in mouse corpus striatum during 1-methyl-4-phenylpyridinium neurotoxicity. Neurochemical research. 2004 Jul:29(7):1417-23
[PubMed PMID: 15202774]
[38]
Zhang L, Li D, Cao F, Xiao W, Zhao L, Ding G, Wang ZZ. Identification of Human Acetylcholinesterase Inhibitors from the Constituents of EGb761 by Modeling Docking and Molecular Dynamics Simulations. Combinatorial chemistry & high throughput screening. 2018:21(1):41-49. doi: 10.2174/1386207320666171123201910. Epub
[PubMed PMID: 29173156]
[39]
Ribeiro ML, Moreira LM, Arçari DP, Dos Santos LF, Marques AC, Pedrazzoli J Jr, Cerutti SM. Protective effects of chronic treatment with a standardized extract of Ginkgo biloba L. in the prefrontal cortex and dorsal hippocampus of middle-aged rats. Behavioural brain research. 2016 Oct 15:313():144-150. doi: 10.1016/j.bbr.2016.06.029. Epub 2016 Jul 14
[PubMed PMID: 27424157]
[40]
Barkats M, Venault P, Christen Y, Cohen-Salmon C. Effect of long-term treatment with EGb 761 on age-dependent structural changes in the hippocampi of three inbred mouse strains. Life sciences. 1995:56(4):213-22
[PubMed PMID: 7823780]
[41]
Liu Q, Jin Z, Xu Z, Yang H, Li L, Li G, Li F, Gu S, Zong S, Zhou J, Cao L, Wang Z, Xiao W. Antioxidant effects of ginkgolides and bilobalide against cerebral ischemia injury by activating the Akt/Nrf2 pathway in vitro and in vivo. Cell stress & chaperones. 2019 Mar:24(2):441-452. doi: 10.1007/s12192-019-00977-1. Epub 2019 Feb 27
[PubMed PMID: 30815818]
[42]
Islam BU, Jabir NR, Tabrez S. The role of mitochondrial defects and oxidative stress in Alzheimer's disease. Journal of drug targeting. 2019 Nov:27(9):932-942. doi: 10.1080/1061186X.2019.1584808. Epub 2019 Mar 26
[PubMed PMID: 30775938]
[43]
Li W, Qinghai S, Kai L, Xue M, Lili N, Jihua R, Zhengxiang L, Xiaoling L, Di G, Qi Y, Mengyun D, Jianfeng F. Oral administration of Ginkgolide B alleviates hypoxia-induced neuronal damage in rat hippocampus by inhibiting oxidative stress and apoptosis. Iranian journal of basic medical sciences. 2019 Feb:22(2):140-145. doi: 10.22038/ijbms.2018.26228.6569. Epub
[PubMed PMID: 30834078]
Level 2 (mid-level) evidence
[44]
Tian J, Liu Y, Chen K. Ginkgo biloba Extract in Vascular Protection: Molecular Mechanisms and Clinical Applications. Current vascular pharmacology. 2017:15(6):532-548. doi: 10.2174/1570161115666170713095545. Epub
[PubMed PMID: 28707602]
[45]
Auguet M, Delaflotte S, Hellegouarch A, Clostre F. [Pharmacological bases of the vascular impact of Ginkgo biloba extract]. Presse medicale (Paris, France : 1983). 1986 Sep 25:15(31):1524-8
[PubMed PMID: 2947093]
[46]
Shen J, Wang J, Zhao B, Hou J, Gao T, Xin W. Effects of EGb 761 on nitric oxide and oxygen free radicals, myocardial damage and arrhythmia in ischemia-reperfusion injury in vivo. Biochimica et biophysica acta. 1998 Apr 28:1406(3):228-36
[PubMed PMID: 9630646]
[47]
Li Q, Ye T, Long T, Peng X. Ginkgetin exerts anti-inflammatory effects on cerebral ischemia/reperfusion-induced injury in a rat model via the TLR4/NF-κB signaling pathway. Bioscience, biotechnology, and biochemistry. 2019 Apr:83(4):675-683. doi: 10.1080/09168451.2018.1553608. Epub 2018 Dec 20
[PubMed PMID: 30570395]
[48]
Braquet P, Hosford D. Ethnopharmacology and the development of natural PAF antagonists as therapeutic agents. Journal of ethnopharmacology. 1991 Apr:32(1-3):135-9
[PubMed PMID: 1881152]
[49]
Naderi GA, Asgary S, Jafarian A, Askari N, Behagh A, Aghdam RH. Fibrinolytic effects of Ginkgo biloba extract. Experimental and clinical cardiology. 2005 Summer:10(2):85-7
[PubMed PMID: 19641664]
[50]
O'Hara M, Kiefer D, Farrell K, Kemper K. A review of 12 commonly used medicinal herbs. Archives of family medicine. 1998 Nov-Dec:7(6):523-36
[PubMed PMID: 9821826]
[51]
Unger M. Pharmacokinetic drug interactions involving Ginkgo biloba. Drug metabolism reviews. 2013 Aug:45(3):353-85. doi: 10.3109/03602532.2013.815200. Epub
[PubMed PMID: 23865865]
[52]
Kellermann AJ, Kloft C. Is there a risk of bleeding associated with standardized Ginkgo biloba extract therapy? A systematic review and meta-analysis. Pharmacotherapy. 2011 May:31(5):490-502. doi: 10.1592/phco.31.5.490. Epub
[PubMed PMID: 21923430]
Level 1 (high-level) evidence
[53]
Bent S, Goldberg H, Padula A, Avins AL. Spontaneous bleeding associated with ginkgo biloba: a case report and systematic review of the literature: a case report and systematic review of the literature. Journal of general internal medicine. 2005 Jul:20(7):657-61
[PubMed PMID: 16050865]
Level 3 (low-level) evidence
[54]
Rosenblatt M, Mindel J. Spontaneous hyphema associated with ingestion of Ginkgo biloba extract. The New England journal of medicine. 1997 Apr 10:336(15):1108
[PubMed PMID: 9091822]
[55]
Stoddard GJ, Archer M, Shane-McWhorter L, Bray BE, Redd DF, Proulx J, Zeng-Treitler Q. Ginkgo and Warfarin Interaction in a Large Veterans Administration Population. AMIA ... Annual Symposium proceedings. AMIA Symposium. 2015:2015():1174-83
[PubMed PMID: 26958257]
[57]
Jang HS, Roh SY, Jeong EH, Kim BS, Sunwoo MK. Ginkgotoxin Induced Seizure Caused by Vitamin B6 Deficiency. Journal of epilepsy research. 2015 Dec:5(2):104-6. doi: 10.14581/jer.15018. Epub 2015 Dec 31
[PubMed PMID: 26819944]
[58]
Harms SL, Garrard J, Schwinghammer P, Eberly LE, Chang Y, Leppik IE. Ginkgo biloba use in nursing home elderly with epilepsy or seizure disorder. Epilepsia. 2006 Feb:47(2):323-9
[PubMed PMID: 16499756]
[59]
Xin QQ, Liu Y, Yang L, Fu CG, Chen KJ. [Ginkgo preparations of Chinese medicine and treatment of diabetes: mechanisms and clinical applications]. Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica. 2014 Dec:39(23):4509-15
[PubMed PMID: 25911792]
[60]
Pennisi RS. Acute generalised exanthematous pustulosis induced by the herbal remedy Ginkgo biloba. The Medical journal of Australia. 2006 Jun 5:184(11):583-4
[PubMed PMID: 16768668]
[61]
Hasegawa S, Oda Y, Ichiyama T, Hori Y, Furukawa S. Ginkgo nut intoxication in a 2-year-old male. Pediatric neurology. 2006 Oct:35(4):275-6
[PubMed PMID: 16996402]